Sosei Group Acquires Idorsia Pharma Japan APAC 2023

Sosei Group Corporation announces the acquisition of Idorsia's pharmaceutical business in Japan and APAC (excluding China). The transaction combines Sosei's leading GPCR-targeted drug discovery platform with Idorsia's clinical development capabilities and profitable commercial operations in the region.